Skip to main content
. 2016 Dec 19;32(2):231–239. doi: 10.3346/jkms.2017.32.2.231

Table 1. Baseline characteristics and prevalence of CVD according to the etiology of CKD.

Characteristics Subcohort Total P value
DN HTN GN PKD
Participants 519 409 810 364 2,238
Age, yr 59.3 ± 9.4 59.6 ± 10.8 49.8 ± 12.1 46.9 ± 10.6 53.7 ± 12.2 < 0.001
Female 162 (31.2) 114 (27.9) 359 (44.3) 180 (49.5) 869 (38.8) < 0.001
Hypertension 513 (99.8) 409 (100.0) 785 (96.9) 314 (86.3) 2,150 (96.1) < 0.001
DM 519 (100.0) 72 (17.6) 70 (8.6) 12 (3.3) 755 (33.7) < 0.001
Current smoker 84 (16.4) 71 (17.4) 115 (14.2) 55 (15.1) 349 (15.7) < 0.001
Height, cm 164.5 ± 8.2 164.8 ± 8.2 164.3 ± 8.2 166.1 ± 9.1 164.7 ± 8.4 0.040
Weight, kg 68.4 ± 11.4 68.4 ± 12.3 65.6 ± 11.7 65.2 ± 12.0 66.8 ± 11.9 < 0.001
BMI, kg/m2 25.2 ± 3.2 25.1 ± 3.5 24.2 ± 3.3 23.5 ± 3.0 24.6 ± 3.4 < 0.001
Waist-to-hip ratio 0.93 ± 0.06 0.91 ± 0.06 0.88 ± 0.07 0.88 ± 0.06 0.90 ± 0.07 < 0.001
SBP, mmHg 134.3 ± 18.5 127.8 ± 15.9 123.4 ± 14.2 128.3 ± 13.3 127.8 ± 16.2 < 0.001
DBP, mmHg 75.7 ± 11.7 77.7 ± 11.5 75.6 ± 10.1 81.0 ± 10.4 77.0 ± 11.1 < 0.001
CKD stages < 0.001
 Stage 1 13 (2.5) 11 (2.7) 131 (16.2) 94 (25.8) 265 (11.8)
 Stage 2 44 (8.5) 48 (11.7) 180 (22.2) 118 (32.4) 419 (18.7)
 Stage 3a 72 (13.9) 95 (23.2) 163 (20.1) 52 (14.3) 403 (18.0)
 Stage 3b 131 (25.2) 112 (27.4) 158 (19.5) 45 (12.4) 484 (21.6)
 Stage 4 198 (38.2) 118 (28.9) 138 (17.0) 42 (11.5) 522 (23.3)
 Stage 5 61 (11.8) 25 (6.1) 40 (4.9) 13 (3.6) 145 (6.5)
CVD
 Any CVD 130 (25.0) 88 (21.5) 56 (6.9) 25 (6.9) 322 (14.4) < 0.001
 Coronary disease 60 (11.6) 32 (7.8) 14 (1.7) 2 (0.5) 118 (5.3) < 0.001
 MI 18 (3.5) 9 (2.2) 6 (0.7) 1 (0.3) 36 (1.6) < 0.001
 Stroke 51 (9.8) 38 (9.3) 19 (2.3) 21 (5.8) 135 (6.0) < 0.001
 PAD 32 (6.2) 20 (4.9) 13 (1.6) 1 (0.3) 78 (3.5) < 0.001
 Arrhythmia 16 (3.1) 18 (4.4) 18 (2.2) 2 (0.5) 56 (2.5) 0.006
Urine ACR, mg/g < 0.001
 A1 (< 30) 21 (4.3) 101 (26.1) 44 (5.8) 151 (42.9) 336 (15.9)
 A2 (30–300) 101 (20.5) 126 (32.6) 214 (28.4) 169 (48.0) 641 (30.4)
 A3 (≥ 300) 370 (75.2) 160 (41.3) 496 (65.8) 32 (9.1) 1,134 (53.7)
Creatinine, mg/dL 2.4 ± 1.3 2.0 ± 1.2 1.6 ± 1.0 1.3 ± 0.9 1.8 ± 1.1 < 0.001
Cystatin C, mg/L 2.3 ± 1.0 1.9 ± 0.9 1.6 ± 0.9 1.3 ± 0.7 1.8 ± 0.9 < 0.001
eGFR, mL/min/1.73 m2 35.2 ± 20.6 40.8 ± 21.2 56.9 ± 31.8 68.1 ± 33.3 50.5 ± 30.3 < 0.001
Total cholesterol, mg/dL 178.9 ± 33.5 167.3 ± 43.7 169.3 ± 35.6 178.4 ± 39.0 178.9 ± 33.5 < 0.001
LDL cholesterol, mg/dL 91.0 ± 33.9 94.1 ± 30.8 100.1 ± 32.4 101.8 ± 27.1 96.9 ± 31.8 < 0.001
HDL cholesterol, mg/dL 43.6 ± 14.1 46.7 ± 14.1 51.5 ± 15.8 54.6 ± 14.0 49.2 ± 15.4 < 0.001
Hemoglobin, g/dL 11.7 ± 1.8 13.3 ± 2.0 13.2 ± 1.9 13.2 ± 1.8 12.8 ± 2.0 < 0.001
Albumin, g/dL 4.0 ± 0.5 4.3 ± 0.3 4.1 ± 0.4 4.4 ± 0.3 4.2 ± 0.4 < 0.001
Phosphorus, mg/dL 4.0 ± 0.8 3.6 ± 0.6 3.6 ± 0.6 3.6 ± 0.6 3.7 ± 0.7 < 0.001
Troponin T, ng/mL 0.029 ± 0.031 0.015 ± 0.015 0.01 ± 0.009 0.007 ± 0.004 0.015 ± 0.019 < 0.001
hsCRP, mg/L* 0.7 (0.1–52.7) 0.8 (0.0–67.0) 0.5 (0.0–68.0) 0.4 (0.0–35.3) 0.6 (0.0–68.0) < 0.001
Intact PTH, pg/mL* 63.4 (14.2–1,078.0) 52.3 (19.1–660.3) 44.4 (7.0–552.3) 56.3 (21.8–414.9) 51.0 (7.0–1,078.0) < 0.001
ARB 419 (80.7) 318 (77.8) 669 (82.6) 270 (74.2) 1,785 (79.8) 0.025
ACEi 63 (12.1) 33 (8.1) 123 (15.2) 18 (4.9) 249 (11.1) < 0.001
CCB 295 (56.8) 218 (53.3) 216 (26.7) 120 (33.0) 906 (40.5) < 0.001
Statin 329 (63.4) 234 (57.2) 419 (51.7) 98 (26.9) 1,152 (51.5) < 0.001

Values are presented as number (%) or mean ± standard deviation.

CVD = cardiovascular disease, CKD = chronic kidney disease, DN = diabetic nephropathy, HTN = hypertensive nephropathy, GN = glomerulonephritis, PKD = polycystic kidney disease, BMI = body mass index, DM = diabetes mellitus, SBP = systolic blood pressure, DBP = diastolic blood pressure, MI = myocardial infarction, PAD = peripheral arterial disease, ACR = albumin-to-creatinine ratio, eGFR = estimated glomerular filtration rate, LDL = low-density lipoprotein, HDL = high-density lipoprotein hsCRP = high-sensitive C-reactive protein, PTH = parathyroid hormone, ARB = angiotensin receptor blocker, ACEi = angiotensin converting enzyme inhibitor, CCB = calcium channel blocker.

*Data are expressed as median and ranges (minimum to maximum).